The Fort Worth Press - Who should get paid for nature's sequenced genes?

USD -
AED 3.672499
AFN 64.501308
ALL 81.091764
AMD 369.248031
ANG 1.789884
AOA 917.999814
ARS 1395.523747
AUD 1.382485
AWG 1.8
AZN 1.698555
BAM 1.662466
BBD 2.013854
BDT 122.689218
BGN 1.668102
BHD 0.377545
BIF 2976.339735
BMD 1
BND 1.267973
BOB 6.9098
BRL 4.914103
BSD 0.999873
BTN 94.420977
BWP 13.425192
BYN 2.825886
BYR 19600
BZD 2.010964
CAD 1.36575
CDF 2316.000248
CHF 0.778435
CLF 0.022607
CLP 889.770183
CNY 6.80505
CNH 6.80103
COP 3738.9
CRC 459.648974
CUC 1
CUP 26.5
CVE 93.718924
CZK 20.662698
DJF 178.070373
DKK 6.35355
DOP 59.467293
DZD 132.269335
EGP 52.717905
ERN 15
ETB 156.137601
EUR 0.85023
FJD 2.184898
FKP 0.734821
GBP 0.734715
GEL 2.679792
GGP 0.734821
GHS 11.264445
GIP 0.734821
GMD 72.999787
GNF 8773.107815
GTQ 7.634866
GYD 209.223551
HKD 7.82816
HNL 26.583478
HRK 6.404025
HTG 130.919848
HUF 302.820499
IDR 17368.9
ILS 2.90496
IMP 0.734821
INR 94.478103
IQD 1309.963492
IRR 1312900.000029
ISK 122.270146
JEP 0.734821
JMD 157.601928
JOD 0.708974
JPY 156.754504
KES 129.130063
KGS 87.420497
KHR 4012.087263
KMF 419.000313
KPW 899.950939
KRW 1466.68497
KWD 0.30763
KYD 0.833358
KZT 462.122307
LAK 21929.626969
LBP 89547.492658
LKR 321.915771
LRD 183.493491
LSL 16.405102
LTL 2.952741
LVL 0.60489
LYD 6.322723
MAD 9.144703
MDL 17.099822
MGA 4176.618078
MKD 52.401617
MMK 2099.606786
MNT 3578.902576
MOP 8.06268
MRU 39.968719
MUR 46.820195
MVR 15.454972
MWK 1733.612706
MXN 17.23635
MYR 3.920978
MZN 63.900189
NAD 16.405102
NGN 1359.689667
NIO 36.794016
NOK 9.20175
NPR 151.087386
NZD 1.67806
OMR 0.384529
PAB 0.999962
PEN 3.457057
PGK 4.415452
PHP 60.485968
PKR 278.66746
PLN 3.598017
PYG 6107.687731
QAR 3.654753
RON 4.440951
RSD 99.791978
RUB 74.148427
RWF 1465.941884
SAR 3.780624
SBD 8.032258
SCR 14.326153
SDG 600.498337
SEK 9.218875
SGD 1.267885
SHP 0.746601
SLE 24.600677
SLL 20969.496166
SOS 571.467429
SRD 37.43097
STD 20697.981008
STN 20.823594
SVC 8.749309
SYP 110.543945
SZL 16.394307
THB 32.224021
TJS 9.329718
TMT 3.51
TND 2.904513
TOP 2.40776
TRY 45.36475
TTD 6.776593
TWD 31.394497
TZS 2604.644023
UAH 43.92104
UGX 3746.547108
UYU 39.879308
UZS 12128.681314
VES 496.20906
VND 26308
VUV 118.026144
WST 2.704092
XAF 557.575577
XAG 0.012389
XAU 0.000212
XCD 2.70255
XCG 1.802048
XDR 0.695511
XOF 557.525817
XPF 101.364158
YER 238.601522
ZAR 16.42005
ZMK 9001.201083
ZMW 19.037864
ZWL 321.999592
  • CMSC

    0.0000

    22.97

    0%

  • BCC

    -0.3800

    72.38

    -0.53%

  • AZN

    -0.1900

    182.33

    -0.1%

  • NGG

    0.8300

    86.74

    +0.96%

  • BTI

    0.0700

    58.15

    +0.12%

  • BCE

    -0.1350

    24.435

    -0.55%

  • GSK

    -0.3250

    50.175

    -0.65%

  • RBGPF

    0.0000

    63.18

    0%

  • RIO

    1.9900

    105.1

    +1.89%

  • JRI

    0.0000

    13.15

    0%

  • RELX

    -0.0941

    33.41

    -0.28%

  • CMSD

    -0.0200

    23.4

    -0.09%

  • VOD

    0.4300

    16.12

    +2.67%

  • BP

    -0.1150

    43.695

    -0.26%

  • RYCEF

    -1.0000

    16.45

    -6.08%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: © AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

T.Harrison--TFWP